Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
New Year’s SALE: Up to 40% OFF InvestingPro+ CLAIM OFFER
Close

Pfizer Inc (PFE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pfizer's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
43.79 -0.46    -1.04%
27/01 - Closed. Currency in USD ( Disclaimer )
After Hours
43.80
0.01
0.02%
27/01
  • Volume: 22,752,904
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 43.78 - 44.34
Type:  Equity
Market:  United States
Pfizer 43.79 -0.46 -1.04%

PFE Financial Summary

 
See below for an overview of the Pfizer financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

Pfizer Inc. reported earnings results for the third quarter and nine months ended October 02, 2022. For the third quarter, the company reported sales was USD 22,638 million compared to USD 24,035 million a year ago. Net income was USD 8,608 million compared to USD 8,146 million a year ago. Basic earnings per share from continuing operations was USD 1.54 compared to USD 1.45 a year ago. Diluted earnings per share from continuing operations was USD 1.51 compared to USD 1.43 a year ago. Basic earnings per share was USD 1.54 compared to USD 1.45 a year ago. Diluted earnings per share was USD 1.51 compared to USD 1.42 a year ago.For the nine months, sales was USD 76,040 million compared to USD 57,450 million a year ago. Net income was USD 26,378 million compared to USD 18,586 million a year ago. Basic earnings per share from continuing operations was USD 4.7 compared to USD 3.37 a year ago. Diluted earnings per share from continuing operations was USD 4.6 compared to USD 3.31 a year ago. Basic earnings per share was USD 4.71 compared to USD 3.32 a year ago. Diluted earnings per share was USD 4.6 compared to USD 3.27 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

PFE Income Statement

Gross margin TTM 66.17%
Operating margin TTM 39.96%
Net Profit margin TTM 29.81%
Return on Investment TTM 27.93%
 Total Revenue  Net Income
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Dec 31, 2021
Total Revenue 22638 27742 25661
Gross Profit 16601 19572 15707
Operating Income 10149 12739 10352
Net Income 8608 9906 7864

PFE Balance Sheet

Quick Ratio MRQ 1.18
Current Ratio MRQ 1.59
LT Debt to Equity MRQ 35.58%
Total Debt to Equity MRQ 39.94%
 Total Assets  Total Liabilities
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Dec 31, 2021
Total Assets 195350 195290 183841 181476
Total Liabilities 102460 107821 101156 104013
Total Equity 92890 87469 82424 77200

PFE Cash Flow Statement

Cash Flow/Share TTM 4.74
Revenue/Share TTM 17.8
Operating Cash Flow  13.48%
 Cash  Net Change in Cash
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Dec 31, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 5974 6541
Cash From Investing Activities -627 567
Cash From Financing Activities -5761 -6578
Net Change in Cash -487 529
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rickard Costan
Rickard Costan Jan 27, 2023 19:35
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Project Veritas...
Reply
0 0
Report
Anon Anon
Anon Anon Oct 24, 2022 17:24
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Still aiming for sub 40
Reply
0 1
Report
Lee Baldwin
Lee Baldwin Mar 31, 2022 13:02
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Great long term er at this price
Reply
2 1
Report
Death Revenge
Death Revenge Feb 19, 2022 22:30
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
please never effective.inbox me for fast rising stocks
Reply
0 1
Report
Trevor Uren
Trevor Uren Feb 14, 2022 15:19
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Adverse Effects Rife
Reply
1 0
Report
Ali Atat
Ali Atat Jan 20, 2022 8:53
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No logic for drop. This is a 60 Euro stock value
Reply
9 0
Report
Michael Potts
Michael Potts Jan 20, 2022 8:53
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It will drop like a stone, when the FDA release the data.
Reply
1 0
Report
Andrew Lees
Andrew Lees Jan 06, 2022 7:13
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
time to jump ship. New variants are weaker, hospitalisations are down, no longer a need for vaccine or meds. vaccine centres in the UK are now practically empty. It was a good two year ride, but time to bail.
Reply
2 4
Report
Timor Malul
Timor Malul Jan 05, 2022 15:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Strong buyPresident Biden has doubled commitment of the Pfizer pill treatment to at least 20 million courses as the Covid omicron variant rages.
Reply
4 0
Report
Basil Skater
Basil Skater Dec 17, 2021 16:28
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why TF is this not rising ?
Reply
2 0
Report
Andrzej Bagiński
Andrzej Bagiński Nov 19, 2021 17:11
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email